Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06249126 · ClinicalTrials.gov registry record · NA
Primary Subtalar Arthrodesis for Calcaneal Fractures
A NA study of Calcaneus Fracture, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 218
- Enrollment target
- 14
- Study locations
NCT06249126: Recruiting NA study of Calcaneus Fracture, sponsored by Wake Forest University Health Sciences.
NCT06249126 is a NA study of Calcaneus Fracture that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 218 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). The trial reports 14 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06249126, a NA study of Calcaneus Fracture, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 218 participants
- Enrollment target
- 14
- Study locations
Study Summary
Management of severe injuries to the heel (displaced intra-articular calcaneus fractures) continues to be a major challenge for orthopedic surgeons. Previous studies have demonstrated poor outcomes, and results show that patients experience long-term pain and decreased quality of life postoperatively. Poor outcomes are driven by pain, in particular, which is linked to post-traumatic subtalar arthritis.
Primary Outcome
The primary outcome is return to work/duty as measured by the International Physical Activity Questionnaire (IPAQ). The IPAQ is a validated, self-report measure that captures detailed information about participation in a wide range of physical activities, including the number of days and amount of time spent in the previous 7 days. Responses for each type of physical activity are then transformed into the number of Metabolic Equivalent for Tasks (METs), and a METs/week is calculated for each pat
Conditions Studied
Interventions
- PROCEDURE Primary Fusion (Open Reduction Internal Fixation (ORIF) + Primary Subtalar Arthrodesis (PSTA)
- PROCEDURE Open Reduction Internal Fixation (ORIF) only
Study Locations (14)
North Carolina
- University of North Carolina Chapel Hill - Chapel Hill
- Atrium Health Carolinas Medical Center - Charlotte
- OrthoCarolina Foot and Ankle Institute - Charlotte
- Atrium Health Cabarrus - Concord
- Atrium Health Wake Forest Baptist - Winston-Salem
Georgia
- Emory University, Grady Memorial Research Hospital - Atlanta
- Atrium Health Navicent - Macon
Kentucky
- University of Kentucky - Lexington
Louisiana
- Louisiana State University - University Medical Center New Orleans - New Orleans
Maryland
- University of Maryland Medical Center - Baltimore
New York
- NYC Health and Hospital/Bellevue - New York
South Carolina
- Prisma Health - Greenville
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 218 participants |
| Start Date | 2024-09-02 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT06249126 shows while recruiting
NCT06249126 is an interventional study that assigns participants to a tested intervention. The registered 218 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Calcaneus Fracture appearing as the primary indexed condition, and to 2 interventions - of which Primary Fusion (Open Reduction Internal Fixation (ORIF) + Primary Subtalar Arthrodesis (PSTA) is the first listed.
NCT06249126 lists 14 locations in 9 states (North Carolina, Georgia, Kentucky).
Frequently Asked Questions
What is clinical trial NCT06249126 about?
NCT06249126 is a clinical study titled "Primary Subtalar Arthrodesis for Calcaneal Fractures". Management of severe injuries to the heel (displaced intra-articular calcaneus fractures) continues to be a major challenge for orthopedic surgeons. Previous studies have demonstrated poor outcomes, and results show that patients experience long-term pain and decreased quality of life postoperativel...
What is the current status of trial NCT06249126?
This trial is currently recruiting. It is a NA study. The enrollment target is 218 participants. The study started on 2024-09-02. Estimated completion is 2026-12.
What conditions does trial NCT06249126 study?
This clinical trial studies the following conditions: Calcaneus Fracture.
What interventions are being tested in trial NCT06249126?
The interventions under investigation include: Primary Fusion (Open Reduction Internal Fixation (ORIF) + Primary Subtalar Arthrodesis (PSTA) (PROCEDURE), Open Reduction Internal Fixation (ORIF) only (PROCEDURE).
Who is sponsoring clinical trial NCT06249126?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06249126 being conducted?
This trial has 14 study locations across Georgia, Kentucky, Louisiana, Maryland, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06249126's enrollment target sits among peer trials
218 485th of 2000 higher than 1,516 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04693858 · 218 participants · NA
Efficacy Trial of the CALM Intervention
- NCT05909202 · 218 participants · NA
A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
- NCT06000761 · 218 participants · NA
Frequent Standardized Oral Care Using Human Milk in the Neonatal Intensive Care Unit
- NCT06643351 · 218 participants · NA
Intrapartum Glucose Control and Risk of Neonatal Hypoglycemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI